Axitinib(Inlyta)

Axitinib is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma (RCC) following failure of prior systemic therapy.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Axitinib Medication Guide

When to Immediately Discontinue the Use of Axitinib

Discontinue medication if any of the following situations occur:When to Discontinue TreatmentReversible Posterior Leukoencephalopathy Syndrome (RPLS)M···【Read More】
Update: 25 Feb,2026Source: Haiou HealthViews: 69
How to Take Axitinib Correctly

Axitinib is an oral targeted anti-tumor medication classified as a tyrosine kinase inhibitor (TKI). It functions by inhibiting Vascular Endothelial Gr···【Read More】
Update: 25 Feb,2026Source: Haiou HealthViews: 70